Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,565
Total Claims
$583K
Drug Cost
493
Beneficiaries
$1,183
Cost/Patient
Risk Score Breakdown 56/100
Score components are additive. Read full methodology
Peer Comparison vs. 310 Interventional Radiology providers
+726%
Opioid rate vs peers
67.7% vs 8.2% avg
+137%
Cost per patient vs peers
$1,183 vs $498 avg
-33%
Brand preference vs peers
7.8% vs 11.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 726% above the average for Interventional Radiology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Composite risk score of 56/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.7%
Opioid Rate
3,769
Opioid Claims
$289K
Opioid Cost
16.1%
Long-Acting Rate
This provider's opioid prescribing rate of 67.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 432 claims · $431K
Generic: 5,133 claims · $152K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Methylnaltrexone Bromide | 59 | $188K |
| Oxycodone Myristate | 80 | $62K |
| Buprenorphine Hcl | 51 | $51K |
| Hydrocodone/Acetaminophen | 1,456 | $46K |
| Oxycodone Hcl/Acetaminophen | 1,099 | $42K |
| Naloxegol Oxalate | 71 | $27K |
| Hydrocodone Bitartrate | 23 | $23K |
| Oxycodone Hcl | 26 | $16K |
| Buprenorphine | 47 | $14K |
| Pregabalin | 12 | $10K |
| Gabapentin | 522 | $8,087 |
| Linaclotide | 15 | $8,007 |
| Tapentadol Hcl | 11 | $7,220 |
| Tapentadol Hcl | 11 | $6,917 |
| Oxycodone Hcl | 288 | $6,739 |
Prescribing Profile
33
Unique Drugs
56.0
Anomaly Score
Patient Profile
64
Avg Age
62%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data